Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS stock can be seen as either a great pharmacy stock, better than Walgreens, or a poor health insurer compared with United Healthcare. CVS Health becoming a leader in managed care.

CVS Health Beats Estimates, Market Yawns

Dominion Energy

Choosing stocks to buy with an impending bear market can be nerve-wracking, but these three are defensive picks that should hold up no matter what.

3 Stocks to Buy That Will Endure In a Bear Market

Social distancing has blunted the spread of Covid-19 and different parts of the country are starting to see a decrease in new cases. We have largely avoided overwhelming our health care system, and everyone is looking for ways to responsibly restart the economy.

CVS chief medical officer: How coronavirus testing needs to change

What’s the prognosis for CVS stock? Here is what the fundamentals and technical analysis say about buying CVS stock now.

CVS Stock: Is It A Buy Right Now? Here's What Earnings, Charts Show

CVS Health remains on target to expand its new health hub concept to 1,500 stores across the U.S. within the next two years despite the spread of the coronavirus strain COVID-19.

CVS Health Hub Openings On Track Despite Pandemic

CVS earnings have CVS stock ticking lower on Wednesday despite the company beating both EPS and revenue estimates for the quarter.
The post CVS Earnings: CVS Stock Drops Despite Coronavirus Boosting Sales appeared first on InvestorPlace.

CVS Earnings: CVS Stock Drops Despite Coronavirus Boosting Sales

CVS Health (NYSE: CVS) released its quarterly financial results on Wednesday that topped analysts’ estimates for earnings and revenue. The company attributed its upbeat performance to customers stockpiling prescription drugs and related essentials ahead of the Coronavirus lockdown.

CVS Health posts an upbeat financial report as customers stockpiled ahead of COVID-19

Helped by a virus? That's the story for CVS Health in Q1.

3 Key Ways the COVID-19 Pandemic Boosted CVS Health's Q1 Results

The health-care company's Chief Executive Larry Merlo said trends that emerged during the pandemic, such as use of telemedicine and prescription delivery to the home, may con

'Today's norm to tomorrow's everyday routines,' CVS CEO says the pandemic will change customers' shopping, health-care habits

CVS Health Corporation (CVS) CEO Larry Merlo on Q1 2020 Results - Earnings Call Transcript

CVS Health Corp (CVS) CEO Larry Merlo on Q1 2020 Results - Earnings Call Transcript

Within CVS Health's (CVS) Retail/LTC, the coronavirus pandemic results in greater use of 90-day prescriptions and early refills of maintenance medications in the quarter.

CVS Health (CVS) Q1 Earnings Top Estimates, Costs Escalate

CVS Health Corp  on Wednesday said it was sticking to its 2020 forecast and expected a strong second quarter, as reduced medical service use for its Aetna insurance business offset  coronavirus-related expenses and the pandemic's impact on pharmacy sales and prescriptions.

CVS Health maintains 2020 profit forecast despite coronavirus hit

Consumers stocking up to prepare for pandemic lockdowns helped boost the healthcare giant's sales.

CVS Health Beats Expectations in Q1 Due to COVID-19 Fears

CVS Health reported a surge in use of its retail health clinics via telehealth and a big jump in home prescription delivery as Americans stocked up on prescriptions and personal health items amid the spread of the coronavirus strain COVID-19.

CVS Health’s Telehealth Clinic Visits, Home Drug Delivery Surge Amid Coronavirus Pandemic

CVS Health (CVS) delivered earnings and revenue surprises of 17.18% and 5.74%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Q1 Earnings and Revenues Surpass Estimates

CVS Health Corp  on Wednesday posted first-quarter profit above Wall Street estimates, as its pharmacy benefits management business and its drugstores benefited from customers stockpiling medicines due to COVID-19 lockdowns.

CVS Health first-quarter profit beats on COVID-19 stockpiling

The drugstore chain's stores have remained open as an essential retailer during the coronavirus pandemic, and it's also opened drive-thru testing sites.

CVS Health first-quarter revenue rose 8% as customers rushed into stores to buy essentials; shares up

Shares of CVS Health Corp. CVS, +2.10% surged 4.7% in premarket trading Wednesday, after the drug store and health care benefits company reported better-than-expected profit and revenue, as its pharmacy and retail business got a boost from the COVID-19 pandemic.

CVS profit and revenue rise above expectations as COVID-19 provides a boost to pharmacy, retail business

UnitedHealth Group

The health insurance companies have not seen any significant impact of the current coronavirus crisis, and they have fared much better than the broader markets. While UnitedHealth Group has seen 6.8% growth since early February, after the WHO declared the coronavirus a global health emergency.

At Current Levels of $60 Is CVS Health Cheaper Than UnitedHealth Group?

The retail pharmacies have not been immune to the current coronavirus crisis, although they have fared somewhat better than the broader markets. While CVS Health has declined -8% since early February, after the WHO declared the coronavirus a global health emergency, Kroger stock has fared better.

After An 8% Decline Is CVS Health A Better Buy Than Kroger?

Disney

General Motors

Uber

Fiat Chrysler

JetBlue Airways

Raytheon Technologies

T-Mobile US

Over the past two months, we’ve seen an absolute roller-coaster of volatility in the markets, which has been the result of supply chain concerns across the globe and a general slowdown in business, all due to the coronavirus pandemic.

Disney, GM, Uber and More Big Earnings to Watch For This Week

We expect CVS Health (CVS) to have gained from Aetna's addition of new Individual and Group Medicare Advantage members in Q1.

What's in the Cards for CVS Health (CVS) in Q1 Earnings?

The pilot program could expand to include more CVS stores.

UPS and CVS Teaming Up on Florida Drone Drug Deliveries

It was one of several retailers who pledged to host drive-thru sites in mid-March, but the effort to ramp up testing has been delayed by the lack of protective gear and testing kits.

News for CVS Health Stock (CVS)